“In 2019, expect more of the same. More awareness, more regulatory involvement from the FDA and HHS, and more collaboration among manufacturers, healthcare organizations, federal agencies and cybersecurity services firms. And yes, expect more cyber attacks—and an increased sophistication with which they are executed,” said Stephanie Domas, vice president of research and development at MedSec in her recent article, “Medical Device 2019 Cybersecurity: More Awareness, More Regulatory Involvement, More Collaboration”, which was published by MedTech Intelligence earlier this year.
Domas will be speaking at the upcoming MTI conference, Medical Device Cybersecurity: Legacy Device Remediation, Compensating Controls & End-of-Life, held June 4–5 in Boston. She has been vocal about the challenges that medical device manufacturers face (especially the smaller companies) in having the resources to address cybersecurity issues and the collaboration necessary between device makers and hospitals.
In her role at MedSec, Domas leads the development of cybersecurity products and services to support healthcare delivery organizations and medical device manufacturers on a range of areas that include design, architecture, verification, security risk management, regulatory filings, penetration testing, and execution of security best practices in the development of medical devices as well as vulnerability and asset management of connected medical devices in healthcare delivery organizations. She also is part of several standards committees that are involved in improving cybersecurity in medical devices.
To hear more of her insights, register to attend the MTI Medical Device Cybersecurity conference in June. If you can’t make it to Boston, you can participate in the conference as a virtual attendee. Read about Domas’ perspective on the host of issues in medtech cybersecurity in the following articles.